The HIV Functional Cure Potential of UB-421 in ART Stabilized HIV-1 Patients

NCT03743376 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV-1 Infection

Interventions

BIOLOGICAL: UB-421(25 mg/kg) Q2W
BIOLOGICAL: UB-421(25 mg/kg) Q4W

Sponsor

United BioPharma

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]